Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
GPCR Structure Therapeutics
- 20.530
- +0.370+1.84%
Close Mar 11 16:00 ET
- 20.530
- 0.0000.00%
Post 20:01 ET
1.18BMarket Cap-8.77P/E (TTM)
20.600High19.390Low628.10KVolume20.020Open20.160Pre Close12.66MTurnover1.23%Turnover RatioLossP/E (Static)57.34MShares62.74052wk High1.36P/B1.05BFloat Cap19.39052wk Low--Dividend TTM51.29MShs Float75.017Historical High--Div YieldTTM6.00%Amplitude19.390Historical Low20.151Avg Price1Lot Size
Structure Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 53.96%158.23M | 51.84%47.06M | 75.31%45.84M | 28.20%33.32M | 62.93%32.02M | 95.53%102.78M | 139.23%30.99M | 105.98%26.15M | 86.15%25.99M | 51.71%19.65M |
| Selling and administrative expenses | 51.24%49.41M | 23.94%13.57M | 53.40%13.24M | 71.32%11.27M | 74.03%11.34M | 99.61%32.67M | 138.29%10.95M | 144.27%8.63M | 74.01%6.58M | 46.05%6.51M |
| -General and administrative expense | 51.24%49.41M | 23.94%13.57M | 53.40%13.24M | 71.32%11.27M | 74.03%11.34M | 99.61%32.67M | 138.29%10.95M | 144.27%8.63M | 74.01%6.58M | 46.05%6.51M |
| Research and development costs | 55.22%108.81M | 67.08%33.49M | 86.11%32.6M | 13.60%22.05M | 57.43%20.68M | 93.69%70.1M | 139.74%20.04M | 91.21%17.52M | 90.66%19.41M | 54.67%13.14M |
| Operating profit | -53.96%-158.23M | -51.84%-47.06M | -75.31%-45.84M | -28.20%-33.32M | -62.93%-32.02M | -95.53%-102.78M | -139.23%-30.99M | -105.98%-26.15M | -86.15%-25.99M | -51.71%-19.65M |
| Net non-operating interest income expense | 168.93%36.01M | 73.46%10.72M | 344.61%11.95M | 159.65%7.34M | 253.62%6.01M | 965.31%13.39M | 585.79%6.18M | 670.20%2.69M | 3,617.11%2.83M | 2,562.32%1.7M |
| Total other finance cost | -168.93%-36.01M | -73.46%-10.72M | -344.61%-11.95M | -159.65%-7.34M | -253.62%-6.01M | -965.31%-13.39M | -585.79%-6.18M | -670.20%-2.69M | -3,617.11%-2.83M | -2,562.32%-1.7M |
| Other net income (expense) | ||||||||||
| Income before tax | -36.73%-122.22M | -46.46%-36.34M | -44.46%-33.89M | -12.17%-25.98M | -44.89%-26.01M | -74.22%-89.38M | -105.85%-24.82M | -90.03%-23.46M | -66.83%-23.16M | -37.85%-17.95M |
| Income tax | 31.36%310K | 143.59%136K | -77.28%92K | -55.08%53K | 16.00%29K | 1,288.24%236K | -73.33%-312K | 454.79%405K | 84.38%118K | -58.33%25K |
| Net income | -36.72%-122.53M | -48.88%-36.48M | -42.39%-33.98M | -11.83%-26.03M | -44.85%-26.04M | -74.63%-89.62M | -106.34%-24.5M | -92.17%-23.86M | -66.91%-23.28M | -37.41%-17.98M |
| Net income continuous Operations | -36.72%-122.53M | -48.88%-36.48M | -42.39%-33.98M | -11.83%-26.03M | -44.85%-26.04M | -74.63%-89.62M | -106.34%-24.5M | -92.17%-23.86M | -66.91%-23.28M | -37.41%-17.98M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -36.72%-122.53M | -48.88%-36.48M | -42.39%-33.98M | -11.83%-26.03M | -44.85%-26.04M | -74.63%-89.62M | -106.34%-24.5M | -92.17%-23.86M | -66.91%-23.28M | -37.41%-17.98M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -36.72%-122.53M | -48.88%-36.48M | -42.39%-33.98M | -11.83%-26.03M | -44.85%-26.04M | -69.62%-89.62M | -106.34%-24.5M | -92.17%-23.86M | -50.55%-23.28M | -37.41%-17.98M |
| Basic earnings per share | 3.70%-2.34 | -32.66%-0.6368 | 4.76%-0.6 | 10.00%-0.54 | 24.00%-0.57 | -75.89%-2.43 | -54.58%-0.48 | -29.29%-0.63 | 1.12%-0.6 | -46.10%-0.75 |
| Diluted earnings per share | 3.70%-2.34 | -32.66%-0.6368 | 4.76%-0.6 | 10.00%-0.54 | 24.00%-0.57 | -75.89%-2.43 | -54.58%-0.48 | -29.29%-0.63 | 1.12%-0.6 | -46.10%-0.75 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |